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Abstract
Enteropathogenic E. coli (EPEC) is a human pathogen that targets the small intestine, causing severe and often fatal
diarrhoea in infants. A defining feature of EPEC disease is the loss (effacement) of absorptive microvilli (MV) from the surface
of small intestinal enterocytes. Much of our understanding of EPEC pathogenesis is derived from studies using cell lines such
as Caco-2 – the most extensively used small intestinal model. However, previous work has revealed fundamental differences
between Caco-2 cells and in vivo differentiated enterocytes in relation to MV effacement. This, and the high heterogeneity
and low transfection efficiency of the Caco-2 cell line prompted the isolation of several sub-clones (NCL-1–12) to identify a
more tractable and improved in vivo-like cell model. Along with established Caco-2 clones (TC-7, BBE1), sub-clones were
assessed for growth rate, apical surface morphology, epithelial barrier function and transfection efficiency. TC-7 cells
provided the best all-round clone and exhibited highest levels of ectopic gene expression following cell polarisation. Novel
alterations in EGFP-labelled mitochondria, that were not previously documented in non-polarised cell types, highlighted the
potential of the TC-7 model for defining dynamic enterocyte-specific changes during infection. Crucially, the TC-7 cell line
also mimicked ex vivo derived enterocytes with regard to MV effacement, enabling a better dissection of the process.
Effacement activity caused by the EPEC protein Map in the Caco-2 but not ex vivo model, was linked to a defect in
suppressing its Cdc42-dependent functionality. MV effacement activity of the EPEC protein EspF in the TC-7 model was
dependent on its N-WASP binding motif, which is also shown to play an essential role in epithelial barrier dysfunction.
Together, this study highlights the many advantages of using TC-7 cells as a small intestinal model to study host-pathogen
interactions.
Citation: Dean P, Young L, Quitard S, Kenny B (2013) Insights into the Pathogenesis of Enteropathogenic E. coli Using an Improved Intestinal Enterocyte
Model. PLoS ONE 8(1): e55284. doi:10.1371/journal.pone.0055284
Editor: Andrew J. Roe, University of Glasgow, United Kingdom
Received November 5, 2012; Accepted December 21, 2012; Published January 28, 2013
Copyright:  2013 Dean et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by a Faculty Research Fellowship awarded to PD, a BBSRC-funded Studentship for LY and a Wellcome Trust grant
(WT064409MA) awarded to BK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: p.dean@ncl.ac.uk (PD); brendan.kenny@ncl.ac.uk (BK)
Introduction
Cell lines have been instrumental to our understanding of cell
biology and disease. While several intestinal cell lines are available,
Caco-2 is by far the most commonly used model of the small
intestine [1,2] – employed in a broad range of fields such as
pharmacology, nutrition, toxicology and host-pathogen studies
[3,4]. Caco-2 cells spontaneously differentiate in culture to express
prominent features of enterocytes including a microvilli brush
border, tight junctions, many enterocytic enzymes and transport-
ers [1,5,6,7]. Despite their popularity, one of the major limitations
with the Caco-2 model is its heterogeneity, as the parent cell line is
comprised of a mixed cell population. This has a significant impact
on reproducibility of results as Caco-2 cells derived from different
sources may be made up of a vastly different cell populations
[1,4,8]. Extrinsic factors such as culture conditions, seeding
densities and cell passage may also favour specific sub-populations
of cells [1,4], making the parental Caco-2 line less reliable, and
making comparisons of data from different labs more difficult [8].
Furthermore, visualisation of the Caco-2 cell surface at the single
cell level is complicated due to the mixed cell population. To
alleviate these problems, Caco-2 clones have been isolated and
characterised by several laboratories [9,10,11].
Enteropathogenic E. coli (EPEC), which causes severe watery
diarrhoea, specifically targets the human small intestine [12,13].
Like many other enteric bacterial pathogens, EPEC delivers over
20 virulence-related effector proteins directly into the host cell
cytoplasm using a dedicated type three secretion system (TTSS).
Although effectors are critical for EPEC disease, most of our
knowledge on their function is derived from work using non-
intestinal cell types such as HeLa – that are unable to differentiate
into a polarised epithelium. EPEC belongs to a group of enteric
pathogens that causes attaching and effacing (A/E) lesions on the
surface of intestinal cells – a key feature of A/E pathogen disease
[12,14]. A/E lesions are caused by the effacement of host
microvilli along with the formation of an actin-rich pedestal
beneath the bacterium. Pedestal formation is dependent on the
effector protein Tir which, upon delivery into the host cell, inserts
into the host plasma membrane to act as a receptor for the
bacterial outer membrane protein Intimin [15]. We previously
showed that microvilli effacement is caused by the combined
action of 3 effectors (Map, EspF and Tir) delivered into the host
cell [16]. However, this work revealed a crucial difference between
the effector-driven signalling in Caco-2 and ex vivo derived
intestinal biopsy tissue as the EspF effector effaced microvilli in
both tissue types whereas Map only effaced in the Caco-2 model
[16].
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In this study, we attempted to identify Caco-2 clones that
exhibited in vivo-like features of the host-pathogen interaction while
also providing greater experimental tractability. Clones were
tested for transfectability, morphology, growth rate and epithelial
barrier function and whether they supported in vivo-like signalling
with regard to microvilli effacement. The high transfectability of
some clones, even when well differentiated, enabled a real time
analysis of target cell types during EPEC infection. This work
uncovered novel effector functions within polarised cells relating to
the host mitochondria, EPEC-mediated microvilli effacement and
epithelial barrier dysfunction.
Materials and Methods
General procedures, cell lines, plasmids and bacterial
strains
Bacterial strains and plasmids used in this study are given in
Table 1. Bacteria were cultured at 37uC on Luria-Bertani (LB)
agar plates taken from glycerol stocks. Prior to infections, bacteria
were grown at 37uC as standing cultures overnight in LB broth
with appropriate antibiotics (nalidixic acid, kanamycin or carben-
icillin 50, 25 and 100 mg/ml final concentration respectively).
Mammalian cell lines were Caco-2 (ATCC HTB-37), TC-7 [10]
and BBE1 [11]. Cell clones NCL1-12 (this study) were isolated as
described below. All cells were maintained in 75 cm2 flasks using
standard tissue culture procedures as previously described [17].
Every 2 days cells were given fresh Dulbecco’s minimal Eagle
medium (DMEM; Invitrogen) supplemented with 2 mM L-
glutamine (Sigma), 1% non-essential amino acids (Sigma), 16
penicillin/streptomycin (Sigma) and 10% (v/v) heat inactivated
foetal calf serum (Gibco). Prior to confluence, cells were trypsinised
for 20 min and the resulting suspension was seeded into a new
75 cm2 flask, onto a coverslip or membrane filters as previously
described [17].
Immunoblotting to detect translocated effector proteins
Infected cells were washed with cold Phosphate Buffered Saline
pH 7.4 (PBS) and lysed with 0.2% Saponin (w/v) to release the
Table 1. Bacterial strains, plasmids and cell lines used in this study.
Enteropathogenic E.
coli strain Description Source/Reference
Wild type EPEC Prototypical strain E2348/69 [38]
Dmap Lacking the map gene [18]
DespF Lacking the espF gene [39]
Dquad Lacking map, espF, tir and eae (encodes Intimin) genes [40]
DmapespF Lacking map and espF genes [17]
DTTSS Type three secretion mutant deletion for espA [41]
Plasmids Description Source/Reference
pd2-CMV-EGFP Mammalian EGFP expression This study
pEGFP-MITO Mitochondrial targeting sequence of cytochrome c fused to EGFP [23]
pespF pBR322 vector for bacterial expression of espF [20]
p(L16E)espF pBR322 vector for bacterial expression of espF missing the mitochondrial localisation sequence [20]
pespF(D3) the critical arginines of espF in the three SNX9 motifs exchanged for aspartic acid [28]
pespF (A3) espF expression with all three critical leucine in the N-WASP binding motif exchanged for alanine This study
pespF (A2) As above, with only 2 leucine exchanged – L104A and L197A This study
pespF (A1) As above, with only 1 leucine exchanged – L104A This study
pTccp Bacterial expression – espF homologue Tccp [23]
pSK-map pBluescript based bacterial expression vector for map [18]
pSK-mapDTRL pSK-map with the C-terminal DTRL amino acids removed This study
pSK-mapDE78A pSK-map with the E78A substitution Thus study
Cell lines Description Source/Reference
Caco-2 Heterogeneous model for small intestinal enterocytes. ATCC HTB-37
TC-7 Homogeneous Caco-2 clone [10]
HeLa Human cervical carcinoma cells ATCC No. CCL-2
Clones NCL1-NCL12 Caco-2 clones This study
BBE1 Caco-2 clone with dense brush border [11]
Primers
P1-E78A GCAATGGTTCAAGCAAGCGCAGATTACTTTTCTATCC
P-DTRL PS CGGAATTCATGTTTAGTCCAACGGC
P-DTRL NS CGGTCGACCTAATCCTGCACATTGTC
P-EspF NW NS CGATAGTTCATAGGCAGCTGCTGCATGATCTTTTAGTGCCTGTGC
doi:10.1371/journal.pone.0055284.t001
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Figure 1. Characterisation of Caco-2 clones. Twelve clones (NCL1-12) were isolated by limited dilution and assessed by electron microscopy (A),
growth rate (B), electrical resistance (C) and transfection efficiency (D). The high magnification of clone NCL3 shows the long microvilli (A) while clone
NCL2 at 15 day post-confluence was covered in a glycocalyx-like material. A modified transfection protocol (E) was employed to achieve high levels
TC-7 Cells – A Model to Study EPEC Pathogenesis
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cytosolic fraction. Cells were sedimented (13,000 g65 minutes)
and the pellet was solubilised with 1% (w/v) Triton X-100 to
release the membrane fraction followed by centrifugation
(13,000 g65 minutes). All lysis solutions contained a protease
inhibitor cocktail (Sigma). The protein concentration of the
cytoplasmic and membrane fractions were determined using
Bradford reagent and 20 mg of protein was resolved by 12%
SDS PAGE. Proteins were transferred to nitrocellulose, blocked in
5% milk powder/PBS and probed with antibodies against Tir,
EspF and EspB (obtained commercially from Dr Roger James
Department of Surgery, Leicester University). Western blot was
carried out using an alkaline phosphatase-conjugated secondary
rabbit antibody (Jackson Laboratories) and the signal was
developed using the NBT/BCIP reagent (Pierce).
Scanning electron and confocal microscopy
Polarised epithelial cells were infected with bacterial strains as
previously described [16] using an MOI of 1:30. Scanning electron
microscopy was carried out as described previously [16].
Quantification of microvilli effacement was carried out using the
freely available software package Image J by determining the
percentage level of peripheral effacement in randomly selected
fields from 3 separate experiments. Individual microcolonies were
assessed for their ability to cause peripheral microvilli effacement;
expressed as percentage of the total microcolony count. Indirect
immunofluorescence was carried out using a Leica SP2 confocal
microscope. Polarised cells grown on membrane filters (Corning)
perforated with 0.4 mm pores were fixed for 15 min in 2.5%
paraforamaldehyde/PBS and permeabilised in 0.2% Triton X-
of transfection of the clones. Transfection efficiency (D) was determined in polarised host cells (10 days) following expression of EGFP under a
constitutive CMV promoter (F). All data points represent means 6 SE, n = 3.
doi:10.1371/journal.pone.0055284.g001
Figure 2. EPEC induces toroidal-shaped mitochondria in polarised TC-7 cells. Expression of a mitochondrial-targeted EGFP protein in
polarised TC-7 cells shows a high level of transfection efficiency with occludin staining pattern confirming polarisation (A). Live cell imaging of EGFP-
labelled mitochondria was performed in polarised TC-7 cells infected with a type three secretion system (DTTSS) defective mutant (espA) or wild type
(WT) EPEC (B). Selected image captures are given with the infection time (left) (B). Captured images show the spatial organisation of mitochondria in
cells infected with the two mutants. Arrows show the doughnut shaped (toroidal) mitochondria (B). Toroidal mitochondria were derived from a fusion
of individual mitochondria (pseudocoloured; D). Late stage infected cells (60 min) containing many toroidal mitochondria (pseduocoloured red; E),
quantified in (F). Toroidal-shaped mitochondria were defined as a continuous ring surrounding a central void. Data represents the mean 6 SD, n= 3.
doi:10.1371/journal.pone.0055284.g002
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100. Cells were stained with DAPI (Invitrogen), phalloidin (Alexa
594-conjugated; Invitrogen) and immuno-stained using rabbit
antibodies for occludin (Abcam) or ZO-1 (Abcam). These were
detected with secondary an anti-rabbit antibodies conjugated to
alexa-488 (Invitrogen).
Clonal selection of Caco-2 cells
Selection of Caco-2 clones was carried out by limited dilution.
Cells in exponential phase were trypsinised and serially diluted
into 150 mm culture dishes (Corning) in culture medium. Single
adherent cells were identified by microscopy and after several days
of growth, colonies (3–6 mm diameter) were isolated using 10 mm
cell cloning cylinders (Millipore). Colonies were trypsinised and
sub-cultured, first in 24-well plates, then in tissue culture flasks.
Clones were used after 3 passages and frozen for long term
storage.
Ectopic gene expression in polarised Caco-2 clones
Cell cultures were trypsinised as above and diluted in DMEM
(without supplements) to a concentration of 26106 cells/mL in
suspension. A lipofectamine 2000 (Invitrogen):plasmid DNA mix
(made according to the manufacturer’s instructions except the
DNA concentration was three times the suggested level) was
incubated with the cell suspension then rotated at 37uC for
30 minutes. Cells were immediately sedimented onto 13 mm
sterile glass coverslips within a 24-well plate (Corning) by
centrifugation at 500 g for 5 minutes. Following subsequent
incubation for 6 h at 37uC, the medium was replaced with
complete DMEM. Using this method, adherent cells were
confluent by 24 h post-transfection. The following day, adherent
cells were transfected once more using the same liposome:DNA
concentrations as described above, according to the manufactur-
er’s instructions. Transfected cells were then left to polarise for 10–
15 days.
Transepithelial electrical resistance (TER) and growth
determination of Caco-2 clones
For TER studies, cells were grown on permeable polyester
filters with a 0.4 mm pore size (Corning) for 12–15 days and
infected with the indicated EPEC strains as described previously
[17]. The electrical resistance was measured at 37uC over a 6 h
post-infection period using an EVOM epithelial voltohmeter
(World Precision Instruments). Growth rate of the clones was
determined in a 24 well plate seeded with 16105 cells. When the
fastest clone (clone NCL4) had reached 100% confluence, the
confluence of the remaining clones was determined by microscopy
over 8 fields of view at x400 magnification.
Generation of bacterial and mammalian expression
vectors
Point mutation of Map in its WxxxE motif involved substituting
the critical glutamic acid at position 78 for an alanine residue
(E78A). Mutagenesis was performed with the QuikChange Site-
Directed Mutagenesis kit (Stratagene) using pSK-map [18] as a
template with the primer P1-E78A (Table 1) according to the
manufacturer’s instructions. To remove the last 4 amino acids of
Map, the map variant mapDDTRL was constructed by amplifying
the map gene using pSK-map as a template with primers P-DTRL
PS and NS (Table 1) which re-introduced a stop codon. The
Figure 3. EPEC effacement on TC7 cells mimics in vivo-differentiated enterocytes. Scanning electron microscopy analysis of TC-7 cells
reveals a highly homogeneous densely packed brush border (A) that is effaced by wild type EPEC (B) over a 120 minute infection period. No
peripheral effacement activity was detected during infection with the DespF mutant (C) whereas the Dmap mutant behaved like the wild type strain
(D). A triple mutant (DespFDtirDeae [latter encodes Intimin])hyper-effaced microvilli (E) with removal of Dmap from this strain abolishing effacement
activity (F).
doi:10.1371/journal.pone.0055284.g003
TC-7 Cells – A Model to Study EPEC Pathogenesis
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amplified product was subcloned into pSK-bluescript using EcoRI
and SalI restriction sites. Mutation of the N-WASP binding motif
(NWBM) in EspF was performed by substituting the critical
leucine residues (positions 104, 151 and 197) required for N-
WASP binding and actin nucleation [19] for alanine in each
NWBM. This was performed using the QuikChange Multi Site-
Directed Mutagenesis Kit (Stratagene) with the primer P-EspF
NW NS (Table 1) and using pBR322-espF [20] as a template.
Figure 4. The EspF N-WASP binding motif is critical for effacement activity on TC-7 cells. Schematic of the EspF protein (A) showing
proline rich repeat (PRR) C-terminal domain. Represntative sequence of the sorting nexin 9 (SNX9) and N-WASP binding motifs is shown with the
critical arginine and leucine shown in red in red respectively (A). The diagram on the right shows the D3 EspF variant with the arginines of all 3 SNX9
motifs substituted for aspartic acid. The A3 variant has the critical leucines in all 3 N-WASP motifs replaced with alanine. Scanning electron
microscopy revealed the espF gene could functional complement the espF mutant on TC-7 cell with no role for mitochondrial targeting or the SNX9
binding motif but a crucial role for multiple N-WASP binding motifs (B). Quantification of effacement was performed by assessing percentage of
microvilli removed from the apical surface from 3 separate experiments, 5 fields of view per experiment (C). Data shows mean 6 SE with p values
given in the text. (D) Western blot analysis using antibodies against Tir, EspF and EspB in the cytoplasmic and membrane fractions of cells infected
with the indicated EPEC mutants. (E) Scanning electron micrographs of TC-7 apical surface infected with the quadruple (quad; lacking Tir, Map, EspF
and Intimin) complemented with the indicated plasmids. Effacement in (F) was quantified as in (C).
doi:10.1371/journal.pone.0055284.g004
TC-7 Cells – A Model to Study EPEC Pathogenesis
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Leucine residues were substituted in single, double and triple
combinations and a PvuII restriction site was introduced for
screening purposes. The mammalian expression vector pd2CMV-
EGFP was constructed by subcloning the Not1/EcoRI fragment of
pd2EGFP [21] containing the EGFP gene into the Not1/EcoRI
restriction sites of pEGFP-N1 (Clontech) – thus placing the EGFP
under a constitutive CMV promoter. All new constructs were
verified by sequencing.
Statistical analyses
Unless stated otherwise, experiments were repeated indepen-
dently at least 3 times. Data represents the mean 6 SEM and
where necessary, comparison of means was performed using a
one-way ANOVA with a post-hoc Tukey test to indicate
significant differences between data points; p values less than
0.05 taken as a significant difference.
Results
Isolation and characterisation of Caco-2 clones
The mechanism of EPEC-mediated microvilli effacement
fundamentally differs between enterocytes differentiated in vitro
(Caco-2 model) and in vivo [16]. We speculated that this
discrepancy may relate to the heterogeneity of the Caco-2 model,
thus subclones were isolated (NCL1-12; see Materials and
Methods). These were assessed for surface morphology (by
scanning electron microscopy), ability to polarize and form a
transepithelial electrical resistance, growth rate and transfection
efficiency. In addition, two well established Caco-2 clones, TC-7
[10] and BBE-1 [11], along with the parental cell line were
included in our analyses.
Visual assessment of the clones by scanning electron microscopy
(SEM) revealed homogeneous populations (Figure 1A) although
two clones (NCL8 & 9) exhibited variations of their apical surface
linked to their stage of differentiation. Clone NCL5 deteriorated
with increasing passage and was eventually lost so was not
included in our analysis but all other clones remained stable
following passage. Five clones exhibited a well packed brush
border (TC-7, NCL3, NCL6, NCL10 & NCL12; Figure 1A),
similar to that of in vivo-differentiated enterocytes [16,22]. Notably,
NCL3 had unusually long microvilli (Figure 1A). By contrast,
NCL2 was completely devoid of microvilli, with a denuded surface
covered by a filamentous mesh that became thicker during
differentiation (Figure 1A) – presumably representing a glycocalyx-
like material. The growth rate and TER values for all the clones
was also measured, revealing considerable variation between them
(Figure 1B and C), reinforcing the view that the Caco-2 population
is highly heterogeneous.
Transfection efficiency of Caco-2 clones upon
polarisation
As with non-polarised cell types, a transfectable intestinal
model is highly desirable for studying host-pathogen interactions,
particularly if this model can polarise. Preliminary work using an
EGFP-expression vector indicated that it was not possible to
transfect pre-polarised (7–15 days) cells (not shown). Therefore,
cells were transfected in suspension in their non-polarised state
prior to seeding at high confluency (see Figure 1E). Transfected
cells were left to differentiate for 10–15 days, revealing that a
small sub-population of the parental Caco-2 cell line (,20%),
retained the ability to express EGFP following differentiation,
while the individual Caco-2 clones displayed much higher (and
lower) levels of transfection (Figure 1D). The TC-7 cell line in
particular gave the highest transfection efficiency with over
,60% EGFP positive (Figure 1D–F). Immuno-staining TC-7
cells (Day 10 post confluence) for the tight junctional protein
ZO-1 (data not shown) and occludin (see Figure 2A) supported
the TER data that the cells were polarised. As TC-7 cells
Figure 5. EspF-mediated epithelial barrier dysfunction of TC-7 cells requires the N-WASP binding motif. Loss of epithelial barrier
function as measured by transepithelial electrical resistance (TER) of TC-7 cells infected for 6 h with the indicated EPEC strains. The various DespF
mutants were complemented with DespF variants mutated in the mitochondrial targeting sequence (L16E), the SNX9 binding motif (D3), or 1, 2 or 3
of the N-WASP binding motif (A1, A2, A3 respectively). Data represents the mean 6 SD for 3 independent experiments; p values given in the text.
doi:10.1371/journal.pone.0055284.g005
TC-7 Cells – A Model to Study EPEC Pathogenesis
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exhibited (i) the highest transfection efficiencies of all the clones
tested (ii) relatively quick doubling time (iii) high TER and (iv)
densely packed (in vivo-like) brush border and (iv) have been well
characterised by others [1,10], they were put forward for EPEC
infection studies.
Ectopic gene expression reveals dynamic alterations in
polarised enterocyte mitochondria during EPEC infection
We recently reported that fixed-cell imaging of polarised cells
which express fluorescently-tagged EPEC effectors or epithelial
proteins can provide insights on both epithelial and pathogen
biology [23,24]. However, little is known about dynamic
pathogen-induced changes in polarised cells during infection.
Given that TC-7 cells were amenable to transfection, we
expressed an EGFP fusion protein (EGFP-MITO) in the TC-7
model to label host mitochondria (Figure 2A) as these organelles
are known to be targeted by EPEC during infection [25].
Transfection of TC-7 with EGFP-MITO resulted in a high level
of ectopic gene expression after polarisation (Figure 2A),
supporting the EGFP data (Figure 1F). Infection with an espA
EPEC mutant, which is defective in a functional type three
secretion system (DTTSS), revealed that mitochondria oscillated
short distances with regular frequency (not shown) and main-
tained a relatively consistent shape (Figure 2B). Indeed, the
overall spatial pattern of mitochondria in espA-infected cells
exhibited little change whereas infection with wild type EPEC
resulted in greater mitochondrial movement (Figure 2B). The
most striking phenotype associated with wild type EPEC
infection was the formation of large toroidal (doughnut) shaped
structures (Figure 2B and C) – formed due to mitochondrial end-
to-end fusion (Figure 2D). These structures were not evident in
espA-infected TC-7 cells (Figure 2B and F), suggesting that they
were induced by a delivered bacterial effector(s) protein.
Toroidal-shaped mitochondrial structures increased progressively
during infection and were present in high numbers in late-stage
infected cells (pseudo-coloured red; Figure 2E and F). This data
shows that real time imaging of polarised TC-7 cells can provide
novel insights into the dynamic changes within target host cells
during infection.
An improved in vivo-like model for studying EPEC-
mediated microvilli effacement
Previous reports show that the mechanism of EPEC effacement
is different in Caco-2 and in vivo differentiated enterocytes [16].
SEM analysis revealed the TC-7 model to be a better mimic of in
vivo-differentiated enterocytes as EPEC’s ability to efface microvilli
required EspF but not Map (Figure 3A–D) – as seen with the ex vivo
model [16]. Thus, while the espF mutant could only ‘sink’ into the
brush border (Figure 3C), wild type EPEC and map mutant strains
induced a dramatic loss of peripheral microvilli in the TC-7 model
(Figure 3).
We speculated that the aberrant effacement activity of Map in
the Caco-2 model may be caused by an inability to down-
regulate the Cdc42-dependent signalling triggered by this
effector. As Cdc42-dependent activity of Map has been shown
to be down-regulated by Tir/Intimin [26], effacement activity in
strains deficient in Tir and/or Intimin were assessed with TC-7
cells. An EPEC triple mutant (lacking Tir, EspF and Intimin) was
highly effective at effacing microvilli (Figure 3E) whereas a
quadruple mutant (lacking Map, EspF, Tir and Intimin) was
completely defective (Figure 3F), suggesting that Tir and Intimin
was indeed suppressing this Map-dependent activity. Thus, in
TC-7 cells, and presumably within in vivo enterocytes, Map can
efface microvilli but only when Tir/Intimin are removed.
Interestingly, we found that all strains deficient in Tir or Intimin
exhibited an augmented ‘hyper-effacing’ ability to efface micro-
villi – dependent on the Map effector (similar to the triple
mutant in Figure 3E; data not shown), suggesting Tir/Intimin
strongly suppress Map-induced effacement. As this down-
regulation of Map is not evident in the Caco-2 model [16], this
may explain the differences between the cell lines.
Microvilli effacement by Map and EspF is dependent on
eukaryotic-like motifs
While both Map and EspF target mitochondria, with this
function of EspF abolished by substituting leucine at position 16 to
glutamic acid, their key subversive activities relate to extra-
mitochondrial functions [13]. Thus, Map is a guanine exchange
factor (GEF) that specifically activates Cdc42 in a manner
dependent on a WxxxE motif while the final three residues,
TRL, recruit the Ezrin binding protein 50 (Ebp50) to sustain
Cdc42-dependent signalling [26,27,28,29]. By contrast, EspF
recruits and activates sorting nexin 9 (SNX9) and N-WASP to
remodel host membranes [30,31](Figure 4A). SNX9 binding
motifs have been defined in each of three polyproline rich-repeat
domains [30] with disruption of one (D1) having little impact on
EspF’s subversive activity while disrupting two (D2) or all three
(D3) resulted in reduced or no subversive activity [30] (Figure 4A).
The availability of variants lacking these EspF and Map features
enabled complementation studies to define their involvement in
the effacement process.
SEM analysis of infected TC-7 cells revealed that the
effacement defect of the espF mutant was rescued by introducing
plasmids expressing EspF or the L16E and D3 variants (Figure 4B
and C). As putative N-WASP binding motifs have been defined for
EspF homologues [32], substitutions were introduced to disrupt
one (A1), two (A2) or all three (A3) recruitment motifs (see
Materials and Methods; Figure 4A). While the A1 variant
complemented the espF mutant defect (Figure 4C), the A2 variant
displayed a significant defect and the A3 variant failed to provide
detectable effacing activity (Figure 4B and C; p,0.0001). Indeed,
the strain expressing the A3 variant had a similar defect as the
DespF mutant (p = 0.99) suggesting the A3 variant was unable to
complement the missing espF gene. Western blot confirmed that
the two strains most defective for MV effacement (DespF and the
A3 variant) were able to translocate effectors into host cells similar,
if not better, than the wild type strain (Figure 4D). Thus, EspF’s
ability to efface microvilli in TC-7 cells depends on its N-WASP
binding motif, with no apparent role for mitochondrial targeting
or SNX9 recruitment.
While Map does not exhibit effacing activity in the TC7 or ex
vivo models, its ability to hyper-efface microvilli in the absence of
Tir/Intimin (see Figure 3) provided an opportunity to gain
additional insight into its MV effacement activity. Map
complementation studies with the EPEC quad mutant (lacking
Map, EspF, Tir and Intimin) revealed a critical role for Map’s
WxxxE and -TRL motifs (Figure 4E and F), indicating that
Map’s effacing activity not only depends on its ability to activate
Cdc42 but also to sustain Cdc42-dependent signalling [33].
Taken together this data suggests that effacement of the actin-
rich microvilli by both Map and EspF proteins depends on
eukaryotic-like motifs that are involved in actin nucleation and
polymerisation events.
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The eukaryotic-like N-WASP binding motif of EspF is
multi-functional
As TC-7 cells provide a homogeneous model that mimic in vivo
differentiated enterocytes, they were used to provide additional
insight into another important in vivo-related event – epithelial
barrier dysfunction. EspF is required for EPEC to disrupt the
epithelial barrier [34] but the molecular mechanism is unknown.
Complementation studies with the EspF variants revealed a critical
role for EspF’s N-WASP binding motifs (Figure 5). The DespF
mutant defect was rescued by plasmid expression of native EspF or
the L16E, D3 and A1 variants (p.0.05). By contrast, a partial
defect was evident with the A2 variant while the A3 variant failed
to induce barrier disrupting activity when complementing the
DespF strain and thus was similar to the DespF mutant (p = 0.966).
Thus, N-WASP recruitment by EspF appears to be multi-
functional – inducing effacement of microvilli and causing a
breakdown of the epithelial barrier in TC-7 cells.
Discussion
Key advances in our understanding of host-pathogen interac-
tions have come from the use of host-derived cell lines. For enteric
pathogens, such as enteropathogenic E. coli, Caco-2 cells offer an
attractive small intestinal model because of its morphological and
physiological closeness to the in vivo state. Caco-2 cells are the most
widely used small intestinal model [1,2], employed in several
diverse fields, yet their heterogeneity confers significant problems.
In particular, Caco-2 cells that are sourced from different labs are
likely to consist of vastly different cell populations as extrinsic
factors such as passage time, seeding density and culture medium
can favour certain subpopulations making results less reproducible.
To alleviate these problems, Caco-2 clones have been isolated by
various labs, combining the favourable physiological and mor-
phological features of Caco-2 with the hope of greater experi-
mental tractability and homogeneity.
Our previous work on the mechanism of microvilli effacement
by enteropathogenic E. coli [16] revealed a discrepancy between
Caco-2 cells and in vivo differentiated enterocytes. Thus, while the
EPEC EspF effector was critical in inducing peripheral microvilli
effacement in the ex vivo model, there were redundant roles for
Map and EspF in Caco-2 cells. To gain further insight into the
mechanisms of effacement, and obtain a tractable small intestinal
model, we isolated and characterised 12 Caco-2 clones by limited
dilution. Variation between the clones in growth rate, electrical
resistance and transfection efficiency suggested our parent cell line
was highly heterogeneous – a likely consequence of being derived
directly from ATCC with few passages. Several clones shared
growth, TER, transfection and surface morphologies with the TC-
7 clone suggesting they may be derived from the same clonal cell
type. However, as the TC-7 clone is well characterised [10] with a
microvillar surface similar to in vivo-polarised cells and displayed
the highest level of transfection, it was first to be examined in the
MV effacement assay.
EPEC is known to cause mitochondrial dysfunction and swelling
in HeLa cells [18]. In the present study, live cell imaging of
infected TC-7 cells revealed a mitochondrial fusion event not seen
in other cell types, that resulted in toroidal-shaped mitochondrial
structures – dependent on EPEC expressing a functional effector
delivery system. Toroidal mitochondria are reported to occur as a
consequence of mitochondrial fusion between 2–3 mitochondria
during cell stress and has been linked to their detachment from the
cytoskeleton [35]. An increase in fusion or inhibition in fission of
mitochondria can also lead to similar donut-shaped mitochondria
[36], dependent on host proteins such as human PINK1 [36].
Although we found that such donut-shaped structures increased
progressively during infection with EPEC, it is unclear whether
they are specifically induced by the bacterium or whether they are
a downstream consequence of effector activities. Many EPEC
effectors disrupt the cytoskeleton which may inadvertently result in
mitochondrial detachment leading to the increase in fusion as
previously documented [36]. As toroidal mitochondria in EPEC-
infected cells have not been visualised previously [18] [25], this
highlights the benefits of real-time imaging with a polarised
enterocyte monolayer. Live-cell imaging of TC-7 cells using other
host specific markers may uncover more novel alterations during
infection.
One of the major findings of this study was using TC-7 cells to
uncover molecular events that underpin EPEC-induced microvilli
effacement – a key feature of disease by this pathogen. Infected
TC-7 cells behaved like ex vivo-derived intestinal tissue with an
essential role for EspF but not Map in peripheral MV effacement.
The absolute requirement of the EspF N-WASP binding motifs
(NWBM) for microvilli effacement suggested that either directly or
indirectly, N-WASP may be involved in maintaining the microvilli
stability in the host cell. No role in the effacement process was
found for EspF’s sorting nexin 9 binding motif or mitochondrial
targeting which have both been ascribed other specific functions
during infection [31]. The essential role of the NWBM in
effacement was strikingly similar to epithelial barrier dysfunction
suggesting a related signalling pathway is subverted in both cases.
Thus, EPEC employs the same function of EspF to trigger spatially
and temporally distinct subversive events.
The regulation of effectors inside the host cell appears to be a
tightly controlled event. We have previously shown that the EPEC
proteins Tir and or Intimin regulate the functions of other EPEC
effectors [26,37]. In the present study, Map played no observable
role in effacement in TC-7 cells, but removal of Tir and Intimin
resulted in a Map-induced hyper-effacement that was entirely
dependent on Map’s C-terminal PDZ binding (-TRL) and WxxxE
motif. Both these motifs are essential for Map’s ability to activate
Cdc42 [33], suggesting this pathway is involved in the hyper-
effacement process. Thus, the molecular details that are respon-
sible for effacement of microvilli are starting to be uncovered
although paradoxically for Map and EspF, these appear to involve
actin polymerisation and not depolymerisation functions. Howev-
er, whether Cdc42 or N-WASP are involved directly or indirectly
in preventing microvili destabilisation in the host cell is unclear.
We propose that TC-7 cells are a better model of in vivo-
polarised enterocytes to investigate EPEC pathogenesis. They offer
advantages including high transfection efficiency and densely
packed brush border and crucially appear to mimic in vivo-related
signalling events better than the parental Caco-2 cell line. The
homogeneous nature of this clone would enable more accurate
comparisons of data from different labs compared with the
variable Caco-2 model and therefore will hopefully be adopted by
others.
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